Showing posts with label i.p. chemotherapy. Show all posts
Showing posts with label i.p. chemotherapy. Show all posts
Sunday, August 22, 2010
(abstract) From randomized trial to practice: single institution experience using the GOG 172 i.p. chemotherapy regimen for ovarian cancer — Ann Oncol
Background: The objective of the study was to evaluate completion rates and toxic effects of an i.p. chemotherapy regimen in a cross-section of nonselected patients with ovarian cancer (OC).
Subscribe to:
Posts
(
Atom
)
